We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+31.44%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$719M
AUM Growth
-$27.1M
Cap. Flow
-$214M
Cap. Flow %
-29.71%
Top 10 Hldgs %
66.29%
Holding
201
New
72
Increased
18
Reduced
27
Closed
81

Top Buys

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$7.93M
2
FNB icon
FNB Corp
FNB
+$7.61M
3
SHW icon
Sherwin-Williams
SHW
+$7.06M
4
ALL icon
Allstate
ALL
+$5.58M
5
WTW icon
Willis Towers Watson
WTW
+$5.57M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$274M
2
CE icon
Celanese
CE
+$6.41M
3
MON
Monsanto Co
MON
+$6.27M
4
BG icon
Bunge Global
BG
+$5.97M
5
APD icon
Air Products & Chemicals
APD
+$4.65M

Sector Composition

Rank Sector Weight
1 Financials 19.98%
2 Industrials 5.93%
3 Healthcare 5.67%
4 Technology 4.78%
5 Communication Services 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCPC
176
Balchem Corp
BCPC
$5.38B
– –
-5,557
Closed -$432K
IMGN
177
DELISTED
Immunogen Inc
IMGN
– –
-108,435
Closed -$771K
ARAV
178
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-2,403
Closed -$252K
PRTK
179
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-71,799
Closed -$1.73M
BKI
180
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-7,376
Closed -$302K
NUVA
181
DELISTED
NuVasive, Inc.
NUVA
– –
-18,022
Closed -$1.39M
KDNY
182
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-21,990
Closed -$1.25M
SIOX
183
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-1,802
Closed -$334K
AERI
184
DELISTED
Aerie Pharmaceuticals
AERI
– –
-18,024
Closed -$947K
RDUS
185
DELISTED
Radius Health, Inc.
RDUS
– –
-24,036
Closed -$1.09M
TREC
186
DELISTED
Trecora Resources
TREC
– –
-79,807
Closed -$898K
FRTA
187
DELISTED
Forterra, Inc
FRTA
– –
-42,330
Closed -$348K
GNMK
188
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-36,046
Closed -$426K
WMGI
189
DELISTED
Wright Medical Group Inc
WMGI
– –
-53,877
Closed -$1.48M
AMTD
190
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-53,407
Closed -$2.3M
TTPH
191
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-8,070
Closed -$1.15M
PTLA
192
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-18,305
Closed -$1.03M
DERM
193
DELISTED
Dermira, Inc.
DERM
– –
-19,917
Closed -$580K
AHL
194
DELISTED
ASPEN Insurance Holding Limited
AHL
– –
-29,221
Closed -$1.46M
MON
195
DELISTED
Monsanto Co
MON
– –
-53,000
Closed -$6.27M
AGU
196
DELISTED
Agrium
AGU
– –
-28,500
Closed -$2.58M
ZGNX
197
DELISTED
Zogenix, Inc.
ZGNX
– –
-72,091
Closed -$1.04M
SIVB
198
DELISTED
SVB Financial Group
SIVB
– –
-6,000
Closed -$1.05M
SHPG
199
DELISTED
Shire pic
SHPG
– –
-8,706
Closed -$1.44M
NDRM
200
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-50,468
Closed -$1.51M
5 6 7
8
9

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q3 2017 Portfolio in Review

As of Q3 2017, Crestline Management held 201 positions worth $719M, down 3.6% from $746M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Crestline Management withdrew a net $214M in Q3 2017, closing 81 positions and reducing 27 holdings. Its most notable exit was Celanese, an estimated $6.41M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Crestline Management opened a new position in Travelers Companies worth $7.78M.

  • Crestline Management's largest Q3 2017 buy was Travelers Companies: 63,503 shares worth $7.78M.
  • Crestline Management added most to FNB Corp in Q3 2017, an estimated $7.61M increase.
  • Crestline Management's biggest Q3 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $274M.
  • Crestline Management fully exited Celanese in Q3 2017, selling an estimated $6.41M.
  • Crestline Management's ten largest holdings make up 66% of its $719M portfolio in Q3 2017.
  • Crestline Management opened 72 new positions and closed 81 in Q3 2017.
  • Crestline Management's portfolio value fell 3.6% quarter-over-quarter to $719M.

Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.